ABSTRACT
Background General Practitioners (GPs) play a key role in the treatment of adolescent depression and anxiety in Australia, but their capacity to provide effective care is likely compromised by long wait times for mental health professionals and services.
Aim To explore GPs’ referral practices to mental health treatment and services for adolescents with depression and/or anxiety, their knowledge of wait times and the perceived impact of these on GPs and their patients and proposed acceptable wait times.
Design, Setting and Methods An online survey of 192 GPs in Australia who treated adolescents (12 to 17 years old) with depression and/or anxiety.
Results GPs most frequently referred their adolescent patients with depression and/or anxiety to psychologists and the mean estimated wait time was 57 days (SD: 47.9), which was four times their proposed acceptable wait time (M: 16.7 days, SD: 27.0). The frequency of medication prescribing by GPs almost doubled during the wait time when compared to routine care (14.6% versus 8.3%, respectively). Almost all GPs (81.8%) increased their level of care due to long wait times but had limited training in adolescent mental health or knowledge on appropriate strategies to do so effectively.
Conclusion The findings signify the discrepancies between GPs’ preferences for mental health treatment availability in Australia and what they perceive to be acceptable and the experience of their adolescent patients who they have referred to specialist care. Greater knowledge of wait time strategies, adolescent mental health training, and improved communication between referrer and referred services may help GPs to enhance the quality of primary care provided to adolescent patients with depression and/or anxiety in Australia.
STRENGTHS & LIMITATIONS
This is the first study to examine GPs’ knowledge of wait times for mental health specialists and services for adolescent patients with depression and anxiety in Australia.
The current study is strengthened by its focus on the most common mental health conditions in adolescents, however, different results may be found when examining GPs’ treatment patterns for mental health conditions that may have more immediate need for treatment (e.g. psychosis).
Due to the sample size and self-report nature, the study may not adequately represent the diversity of GPs across Australia or capture the full spectrum of challenges or treatment practices used by GPs.
Future research should explore other non-mental health related patient characteristics or profiles that may be at greater risk of negative effects during the wait time, such as unique developmental needs, socio-economic disadvantage and parental separation.
Additionally, qualitative methods, such as semi-structured interviews, may provide a richer scope of understanding of the impact of wait times on GPs and their rationale for treatment selection.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by a generous donation from the Buxton Family Foundation, Australian Unity, the Frontiers Technology Clinical Academic Group Industry Connection Seed Funding Scheme, and the UNSW Medicine, Neuroscience, Mental Health and Addiction Theme and SPHERE Clinical Academic Group Collaborative Research Funding. BOD is supported by an NHMRC MRFF Investigator Fellowship (MRF1197249). AEW is supported by an NHMRC Investigator Fellowship (2017521). This work is supported by a NHMRC MRFF Million Minds Grant (MRF2035416).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Committee of the University of New South Wales gave ethical approval for this work (HC220107).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We have revised the manuscript title, abstract, and objectives to clarify the aims and focus of the study. We have reduced some of the tables and updated some of the citations.
Data Availability
All data produced in the present study are available upon reasonable request to the Chief Investigator bridianne.odea{at}flinders.edu.au
